Skip to content

Clinical trials

Phase 1/2 Lymphoma, Non-Hodgkin trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 1/2 Country / region: Israel Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20151
20161
20171
20182
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Celgene1
Curis, Inc.1
Hoffmann-La Roche1
Mirror Biologics, Inc.1
Molecular Templates, Inc.1
Nordic Nanovector1
Sheba Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin9
Hematologic Neoplasms3
Lymphoma3
Recurrence3
Hodgkin Disease2
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, B-Cell2
Lymphoma, Follicular2
Lymphoma, Large B-Cell, Diffuse2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.